| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 02/19/2003 | CN1398265A 杂环酰胺衍生物 Heterocyclic amide derivatives |
| 02/19/2003 | CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia |
| 02/19/2003 | CN1397315A Medicine for treating diseases of liver, gallbladder and kidney and its preparing process |
| 02/19/2003 | CN1397314A Medicine for treating diseases of liver, gallbladder and kidney and its preparing process |
| 02/19/2003 | CN1397184A Sijunzi tea |
| 02/19/2003 | CN1101816C Substituted purine derivatives, processes for their prepn. their use, and compsns. comprising them |
| 02/19/2003 | CN1101701C composn. for nasal administration of desmopressin, its prepn. process and use |
| 02/19/2003 | CN1101693C Externally applied Chinese medicine |
| 02/18/2003 | US6521657 Indole derivatives which are agonists of the progesterone receptor and useful for treatment of carcinoma and adenocarcinomas of uterine leiomyomata, endometriosis or polycystic ovary syndorme in a mammal |
| 02/18/2003 | US6521646 Integrin inhibitors |
| 02/18/2003 | US6521645 Methods for the treatment and prevention of urinary stone disease |
| 02/18/2003 | US6521629 2-amine substituted quinoline or quinozoline derivatives useful for treating benign prostatic hyperplasia |
| 02/18/2003 | US6521620 Suppressing tumors, especially breast cancers; antiproli-ferative agents; arthritis, vascular restenosis, psoriasis and angiogenesis; extremely low cytotoxicity |
| 02/18/2003 | US6521270 Compositions comprising nitrofurantoin and uva ursi |
| 02/18/2003 | CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient |
| 02/18/2003 | CA2112237C Cosmetic compositions containing oligosaccharides |
| 02/18/2003 | CA2073042C Phenylethanolamines, drugs containing these compounds, and a method of preparing them |
| 02/13/2003 | WO2003012441A1 Method for detecting modulators of notch signalling |
| 02/13/2003 | WO2003012111A2 Conjugates for the modulation of immune responses |
| 02/13/2003 | WO2003011870A1 Gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | WO2003011868A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/13/2003 | WO2003011864A1 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2a RECEPTOR AND THEIR USE AS MEDICAMENTS |
| 02/13/2003 | WO2003011860A2 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE |
| 02/13/2003 | WO2003011841A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists |
| 02/13/2003 | WO2003011839A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | WO2003011807A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 02/13/2003 | WO2003011317A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | WO2003011314A2 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 02/13/2003 | WO2003011293A2 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | WO2003011262A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 02/13/2003 | WO2003011252A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/13/2003 | WO2003011211A2 Peg-modified uricase |
| 02/13/2003 | WO2002096855A3 Anticholinergic compounds and methods of use |
| 02/13/2003 | WO2002096457A3 Stable liquid formulations of antibodies |
| 02/13/2003 | WO2002076995A3 2-amino-propanol derivatives |
| 02/13/2003 | WO2002051434A3 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 02/13/2003 | WO2002047719A3 Survical promoting ncam binding and ncam ligand biding compounds |
| 02/13/2003 | WO2002038129A3 Delayed-release pharmaceutical formulations containing proinsulin c-peptide |
| 02/13/2003 | WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation |
| 02/13/2003 | WO2001085763A3 Chimeric peptide immunogens their preparation and use |
| 02/13/2003 | US20030032834 Aminoalcohol derivatives |
| 02/13/2003 | US20030032827 Lipoxin compounds and their use in treating cell proliferative disorders |
| 02/13/2003 | US20030032791 Nucleotide sequences coding polypeptide for use in the treatment of metabolic, reproductive and eating disorders |
| 02/13/2003 | US20030032663 Inhibition of the interaction of RAGE with its ligands; treatment acute and chronic inflammation, the development of diabetic late complications, Alzheimer's disease, erectile dysfunction, and tumor invasion and metastasis. |
| 02/13/2003 | US20030032626 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 02/13/2003 | US20030032585 The use of trefoil factor 2 (TFF2) peptides increasing the viscosity of mucus layers in mammals |
| 02/13/2003 | US20030032179 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 02/13/2003 | US20030032097 DNA encoding human vanilloid receptor VR3 |
| 02/13/2003 | US20030031668 Treatment of immune complex disease with anti-CD40L antibodies |
| 02/13/2003 | CA2455833A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 02/13/2003 | CA2455235A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists |
| 02/13/2003 | CA2454937A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | CA2454414A1 Use of 2-alkoxyphenyl-substituted imidazotriazinones |
| 02/13/2003 | CA2453274A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/13/2003 | CA2452665A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 02/13/2003 | CA2452524A1 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 02/13/2003 | CA2451868A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/12/2003 | EP1283260A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof |
| 02/12/2003 | EP1283216A1 Somatostatin analogues binding to all somatostatin receptor subtypes and their use |
| 02/12/2003 | EP1283054A1 Drugs for complications of diabetes and neuropathy and utilization thereof |
| 02/12/2003 | EP1283048A1 Therapeutic agent for improving bladder function or treating urinary disturbance and food and drink containing it |
| 02/12/2003 | EP1283046A1 Preventives and/or remedies for hyperphosphatemia |
| 02/12/2003 | EP1283040A1 Sustained release oral preparations |
| 02/12/2003 | EP1282706A2 Natrium-calcium exchanger protein |
| 02/12/2003 | EP1282699A2 Splice-region antisense composition and method |
| 02/12/2003 | EP1282643A2 Anti-inflammatory compounds and uses thereof |
| 02/12/2003 | EP1282610A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 02/12/2003 | EP1282592A2 Use of amines |
| 02/12/2003 | EP1282426A1 Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 02/12/2003 | EP1282410A2 Novel medical use of aldosterone synthase inhibitors alone or in combination with at1-receptor antagonists |
| 02/12/2003 | EP1282400A2 Pharmaceutical form of administration for peptides, methods for its production and use |
| 02/12/2003 | EP1226239A4 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 02/12/2003 | EP1064262B1 Substituted isoindolones and their use as cyclic gmp modulators in medicaments |
| 02/12/2003 | EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 02/12/2003 | EP0841953B1 Method and apparatus for interstitial radiation of the prostate gland |
| 02/12/2003 | EP0728147B1 Receptor specific atrial natriuretic peptides |
| 02/12/2003 | CN1396921A Pyrrolo-isoquinoline and tetrahydropyrrolo-isoquinoline derivatives and their use as mediators of 5-HT7 reactor |
| 02/12/2003 | CN1396915A Heterocylic derivative, its preparation method and medicine composition containing them |
| 02/12/2003 | CN1396910A Use of vitamin D-derivatives in treatment of osteoporosis and related bone disorders, as well as novel vitamin D3-derivatives |
| 02/12/2003 | CN1396829A New drug combinations |
| 02/12/2003 | CN1395964A Medical usage of simonder wood oil |
| 02/12/2003 | CN1395941A Oral liquid of strawflower |
| 02/12/2003 | CN1101218C Chinese medicine for treating nephrosis |
| 02/12/2003 | CN1101211C Kidney-nourishing pill and its preparing process |
| 02/12/2003 | CN1101208C Medicine for treating uninary calculaus and its preparing process |
| 02/11/2003 | US6518429 Anticancer agents, treating restenosis, atherosclerosis and hepatitis virus |
| 02/11/2003 | US6518292 Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
| 02/11/2003 | US6518279 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 02/11/2003 | US6518277 Disrupting leukocyte function |
| 02/11/2003 | US6518269 Cancer treatment |
| 02/11/2003 | US6517871 Amorphous ammonium salt; blocking angiotensin II receptors; treating hypertension, congestive heart failure and renal failure |
| 02/11/2003 | US6517864 Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder |
| 02/11/2003 | CA2205274C Novel 2,3 disubstituted-(5,6)-heteroarylfused-pyrimidine-4-ones |
| 02/11/2003 | CA2174529C Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof |
| 02/11/2003 | CA2085584C Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists |
| 02/11/2003 | CA2071375C Heterocyclic derivatives |
| 02/11/2003 | CA2041818C Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof as pharmaceutical compositions or as performance enhancers |
| 02/10/2003 | WO2002014320A2 Novel substituted diaryl azepine derivatives as integrin ligands |
| 02/10/2003 | CA2419078A1 Substituted diaryl azepine derivatives as integrin ligands |
| 02/06/2003 | WO2003010298A1 'probiotic lactobacillus salivarius strains |